Focus Financial Network’s Regeneron Pharmaceuticals REGN Stock Holding History

Focus Financial Network’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-469	Closed	-$297K	–	725
2025 Q1	$297K	Sell	469 -7	-1%	-$4.82K	0.01%	549
2024 Q4	$339K	Sell	476 -62	-12%	-$52K	0.01%	515
2024 Q3	$566K	Buy	538 +37	+7%	+$41.2K	0.02%	384
2024 Q2	$544K	Buy	501 +60	+14%	+$58.2K	0.02%	384
2024 Q1	$394K	Hold	441	–	–	0.02%	428
2023 Q4	$387K	Buy	441 +47	+12%	+$38.7K	0.01%	510
2023 Q3	$324K	Hold	394	–	–	0.02%	442
2023 Q2	$283K	Sell	394 -12	-3%	-$9.25K	0.02%	485
2023 Q1	$334K	Buy	406 +75	+23%	+$56.6K	0.02%	430
2022 Q4	$239K	Buy	+331	New	+$244K	0.02%	415

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Focus Financial Network's REGN Position: Q2 2025 in Review

Focus Financial Network sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 469 shares — an estimated $297K sold.

Focus Financial Network first reported a position in REGN in Q4 2022 and held it in 10 quarters. The position peaked at $566K in Q3 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

Focus Financial Network reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Focus Financial Network sold 469 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $297K.
Focus Financial Network first reported a position in Regeneron Pharmaceuticals in Q4 2022 and held it in 10 quarters.
Focus Financial Network's Regeneron Pharmaceuticals position peaked at $566K in Q3 2024.
1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Focus Financial Network's 13F filing for Q2 2025, filed 10 Jul 2025.